2nd MENACTRIMS Congress 2016

Start

Thu, 17 Mar 2016, 09:00

End

Sat, 19 Mar 2016, 12:00

WebSite

http://www.2016.menactrims.com/

Venue:

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS). The main objectives of the organization are as follows:

To support and promote basic and clinical research in multiple sclerosis in the Middle East and North Africa regions
To act as representative of the multiple sclerosis research community
To be actively involved in coordinating initiatives in the field of research both in our region and worldwide in collaboration with national and international MS organizations
To establish National and Regional MS registries and to collaborate database in order to formulate a large MS registry
To develop regular updated guidelines pertaining to diagnosis and therapy of MS in this region
To organize at least bi-annual congresses in the field of treatment and research in multiple sclerosis
To encourage young researchers in the field of multiple sclerosis.
To collaborate with relevant national and local associations in the region to enhance MENACTRIMS mission.

MENACTRIMS is a non-profit organization registered in Amman-Jordan

Exhibit

Symposia

Workshops

Organiser

Sponsor

The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, imaging, epidemiology, differential diagnosis, risk factors, pregnancy, and much more.

The congress will convene over a two-day period to present major updates through plenary sessions, scientific symposia and teaching courses. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In addition, the European Charcot Foundation will participate in the meeting for the first time through a scientific symposium